Verified Nov 2026
Other
·
Latham, New York
·
Since 1988
AngioDynamics is a medical technology company headquartered in Latham, New York, founded in 1988. It designs, manufactures, and sells minimally invasive, image-guided medical devices for restoring blood flow in the vascular system and for cancer treatment, including thrombus management, vascular access, ablation, and NanoKnife systems. It employs roughly 500 to 1,000 people, is privately held, and serves healthcare providers such as interventional radiologists and vascular surgeons, mainly in the United States with international distribution. In July 2026 it reported record fiscal 2026 fourth-quarter and full-year results.
AngioDynamics at a glance
Revenue
$250-500M
Est. band
Employees
500-1,000
Founded
1988
Headquarters
Latham, New York
Certifications
ISO 13485
Import activity
90
Industries
Automotive
Electric Vehicles
Medical
Industrial Equipment
Sourcing and import activity
From US customs bill-of-lading records
US sea imports
90
Named foreign suppliers
14
Top origins
Germany · Hong Kong S.A.R. · Netherlands · Costa Rica
Shared foreign counterparties do not establish that these companies buy from AngioDynamics.
What this tells a buyer
The company reported record fiscal 2026 fourth-quarter and full-year financial results on July 14, 2026, and first-quarter fiscal 2027 results on October 8, 2026.
Its product lines include thrombus management systems, vascular access devices, ablation systems, and NanoKnife systems, and it holds ISO 13485 certification.
The company is privately held, has an estimated annual revenue band of $250 to 500 million, and reports serving markets across more than 50 countries.
Source: US customs bill-of-lading records and public filings · Last verified Nov 05, 2026
STABILITY SIGNALS
Established & active
38 years in operation (founded 1988).
Holds ISO 13485 certification(s) per public sources.
Overview
AngioDynamics is a medical technology company headquartered in Latham, New York, founded in 1988. It designs, manufactures, and sells minimally invasive, image-guided medical devices for restoring blood flow in the vascular system and for cancer treatment, including thrombus management, vascular access, ablation, and NanoKnife systems. It employs roughly 500 to 1,000 people, is privately held, and serves healthcare providers such as interventional radiologists and vascular surgeons, mainly in the United States with international distribution. In July 2026 it reported record fiscal 2026 fourth-quarter and full-year results.
At a glance
Attribute | Detail |
|---|---|
Founded | 1988 |
Headquarters | Latham, New York |
Employees | 500-1,000 |
Revenue | $250-500M (estimated) |
Certifications | ISO 13485 |
What AngioDynamics makes
Its product lines include thrombus management systems, vascular access devices, ablation systems, and NanoKnife systems, and it holds ISO 13485 certification.
Products and capabilities described on the company's own site include LED (source: angiodynamics.com).
Certifications
AngioDynamics is associated with the following certifications in public sources. Confirm the certified scope for the specific plant producing your part:
ISO 13485 — proxyvote.com
Trade and customs footprint
The company reported record fiscal 2026 fourth-quarter and full-year financial results on July 14, 2026, and first-quarter fiscal 2027 results on October 8, 2026. US customs bill-of-lading records list 90 inbound shipments across 14 foreign suppliers, with top origins including Germany · Hong Kong S.A.R. · Netherlands · Costa Rica.
Latest developments
2026-10-08 — AngioDynamics Reports Fiscal Year 2027 First Quarter Financial Results; Continued Execution Drives Med Tech Growth and Profitability - AngioDynamics (angiodynamics.com)
2026-10-02 — AngioDynamics and The PERT Consortium® Name Jacobi Hospital as ALPHA-PE Research Fund Award Recipient to Advance Real-World Pulmonary Embolism Evidence - AngioDynamics (angiodynamics.com)
2026-07-14 — AngioDynamics Reports Record Fiscal Year 2026 Fourth Quarter and Full Year Financial Results; Continued Execution Drives Med Tech Growth and Full-Year Profitability - AngioDynamics (angiodynamics.com)
2026-06-17 — AngioDynamics Receives FDA IDE Approval for RELIEF Feasibility Study Evaluating NanoKnife IRE Platform as Minimally Invasive Treatment for Benign Prostatic Hyperplasia (BPH) - AngioDynamics (angiodynamics.com)
2026-05-28 — AngioDynamics Expands Patient Access to NanoKnife IRE for Prostate and Liver Cancer as Medicare Coverage Framework Takes Effect - AngioDynamics (angiodynamics.com)
2026-02-19 — AngioDynamics Expands Indications for the NanoKnife System Across Europe, Strengthening Multi-Organ Tumor Ablation Platform - AngioDynamics (angiodynamics.com)
Company details
The company is privately held, has an estimated annual revenue band of $250 to 500 million, and reports serving markets across more than 50 countries. AngioDynamics was founded in 1988, has an estimated 500-1,000 employees, and is headquartered in Latham, New York. On the LightSource stability read it is rated "Established & active": 38 years in operation (founded 1988). Holds ISO 13485 certification(s) per public sources.
Frequently asked questions
What does AngioDynamics do?
AngioDynamics is a medical technology company headquartered in Latham, New York, founded in 1988. It designs, manufactures, and sells minimally invasive, image-guided medical devices for restoring blood flow in the vascular system and for cancer treatment, including thrombus management, vascular access, ablation, and NanoKnife systems. It employs roughly 500 to 1,000 people, is privately held, and serves healthcare providers such as interventional radiologists and vascular surgeons, mainly in the United States with international distribution. In July 2026 it reported record fiscal 2026 fourth-quarter and full-year results.
Where is AngioDynamics headquartered?
AngioDynamics is headquartered in Latham, New York (14 Plaza Drive, Latham, New York, 12110).
When was AngioDynamics founded?
AngioDynamics was founded in 1988.
How big is AngioDynamics?
AngioDynamics has an estimated 500-1,000 employees, with revenue in the $250-500M range (estimated).
What certifications does AngioDynamics hold?
AngioDynamics lists ISO 13485 on its website. Confirm the certified scope for the specific plant producing your part.
Does AngioDynamics import from overseas suppliers?
US customs bill-of-lading records show 90 inbound shipments for AngioDynamics, with top origins including Germany · Hong Kong S.A.R. · Netherlands · Costa Rica.
Related suppliers
Explore other suppliers in the LightSource directory:
Last verified Nov 2026. Is this your company? Request a correction.
Location & contact
Evaluating suppliers like these?
This profile comes from a public-data sample of around 1,000 companies. Book a demo to see the full LightSource marketplace and supplier discovery platform — 1M+ credible suppliers, with AI-run sourcing events.